Medical University of Vienna
Vienna, 1050, Austria
NCT Number: NCT01425710
Non-invasive measurements of cardiac output (CO), systemic vascular resistance (SVR), corrected aortic flow time (FTc) and stroke volume (SV) are useful parameters during laparoscopic resection of pheochromocytoma (adrenalectomy) to document the intraoperative changes in volume status and to estimate the volume depletion.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Vienna, 1050, Austria
Pheochromocytomas and extraadrenal paragangliomas are catecholamin-producing tumours deriving from the adrenal medulla and sympathetic ganglia. The only causal therapy is surgical resection. Nowadays, laparoscopic adrenalectomy is thought to be the optimal approach. Chronic volume depletion due to chronic hypertension and preoperative α-adrenoreceptor-blockade (to avoid the effects of intraoperative catecholamine-excess) often lead to hypotension after resection of the tumour. Volume reload with high amounts of fluid is often needed. Therefor some authors recommended invasive measurement (pulmonary artery catheter) to control cardiac output parameters and fluid balance. However, there are non-invasive methods to measure cardiac output(CO), systemic vascular resistance(SVR), stroke volume(SV) and corrected aortic flow time(FTc) to estimate volume status. Except transesophageal echocardiography, other techniques such as transoesophageal doppler and pulse pressure methods exist but have not been investigated during surgical therapy for pheochromocytoma so far. The esophageal Doppler currently represents the "gold standard" for perioperative fluid replacement therapy.
The study's hypothesis is that non-invasive measurements of cardiac output (CO), systemic vascular resistance (SVR), corrected aortic flow time (FTc) and stroke volume (SV) are useful parameters during laparoscopic resection of pheochromocytoma (adrenalectomy) to document the intraoperative changes in volume status and to estimate the volume depletion.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: parameter will be measured continously for the duration of adrenalectomy, an expected average of 3 hours
measured using esophageal doppler
Time frame: parameter will be measured continously for the duration of adrenalectomy, an expected average of 3 hours
measured using esophageal doppler
Time frame: parameter will be measured continously for the duration of adrenalectomy, an expected average of 3 hours
measured using esophageal doppler
Time frame: parameter will be measured continously for the duration of adrenalectomy, an expected average of 3 hours
measured using esophageal doppler
Time frame: parameter will be measured continously for the duration of adrenalectomy, an expected average of 3 hours
Measured using esophageal doppler
Time frame: parameter will be measured continously for the duration of adrenalectomy, an expected average of 3 hours
Time frame: parameter will be measured continously for the duration of adrenalectomy, an expected average of 3 hours
systolic, diastolic, mean; continuous invasive measurement
Time frame: 7 timepoints during anesthesia (Administration of rocuronium, intubation, cut, intraabdominal air insufflation, ligature of v. suprarenalis, tumor exstirpation, end of operation)
Time frame: 7 timepoints during anesthesia (Administration of rocuronium, intubation, cut, intraabdominal air insufflation, ligature of v. suprarenalis, tumor exstirpation, end of operation)
Time frame: 7 timepoints during anesthesia (Administration of rocuronium, intubation, cut, intraabdominal air insufflation, ligature of v. suprarenalis, tumor exstirpation, end of operation)
Time frame: 7 timepoints during anesthesia (Administration of rocuronium, intubation, cut, intraabdominal air insufflation, ligature of v. suprarenalis, tumor exstirpation, end of operation)
Medical University of Vienna
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04573816
Disease Attributes, Neoplasms
Paris, France
View Trial DetailsNCT01022515
Cardiovascular Diseases, Essential Hypertension
Lille, France
View Trial DetailsNCT04400474
Adenocarcinoma, Anaplastic Thyroid Cancer
Badalona, Barcelona, Spain
View Trial DetailsNCT06062082
Neoplasms, Neoplasms by Histologic Type
Nancy, France
View Trial Details